|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: M.N.G. Dukes (Oslo, Norway)Publisher: Elsevier Science & Technology Imprint: Elsevier Science Ltd Dimensions: Width: 16.50cm , Height: 2.20cm , Length: 24.00cm Weight: 0.930kg ISBN: 9780444518682ISBN 10: 0444518681 Pages: 422 Publication Date: 04 November 2005 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Out of Print Availability: In Print ![]() Limited stock is available. It will be ordered for you and shipped pending supplier's limited stock. Table of ContentsPREFACE ACKNOWLEDGEMENTS PART A: THE DEFINITION OF STANDARDS 1. INTRODUCTION: THE PHARMACEUTICAL INDUSTRY AND ITS PRODUCTS 2. SOURCES OF STANDARDS FOR BUSINESS AND INDUSTRY 3. SOURCES OF STANDARDS SPECIFIC TO THE PHARMACEUTICAL INDUSTRY PART B: ACCEPTANCE AND IMPLEMENTATION OF STANDARDS 4. THE INDUSTRY AS A DEVELOPER, MANUFACTURER AND SUPPLIER 5. THE INDUSTRY AS A SOURCE OF INFORMATION, PERSUASION AND EDUCATION 6. PHARMACEUTICAL PRICING AND PROFITS 7. THE INDUSTRY AS INNOVATOR 8. THE INDUSTRY AND THE DEVELOPING WORLD 9. SPECIAL SITUATIONS 10. THE DUTIES OF THE GENERIC MANUFACTURER 11. THE PHARMACEUTICAL INDUSTRY AND SOCIAL CONTROVERSY 12. POSTSCRIPT: THE WAY AHEAD SELECTED REFERENCESReviews...includes stories that led to the adoption of some of the laws and policies, which helps to make the process more accessible... - Jeremy Sugarman, M.D., M.P.H., Johns Hopkins University for THE NEW ENGLAND JOURNAL OF MEDICINE(2006) ...a measured walk through most of the beter-known public policy issues revolving around drug research, marketing and use. - PharmaceuticalCommerce.com (2006) ...Although Dukes doesn't attempt to catalogue all relevant laws, he provides categories and examples that serve as a useful starting point for understanding the types of policies and laws that should be considered in particular cases. In addition, Dukes includes stories that led to the adoption of some of the laws and policies, which helps to make the process more accessible to the reader. - Jeremy Sugarman, M.D., M.P.H., Johns Hopkins University for THE NEW ENGLAND JOURNAL OF MEDICINE(2006) ...a measured walk through most of the beter-known public policy issues revolving around drug research, marketing and use. - PharmaceuticalCommerce.com (2006) ...Although Dukes doesn't attempt to catalogue all relevant laws, he provides categories and examples that serve as a useful starting point for understanding the types of policies and laws that should be considered in particular cases. In addition, Dukes includes stories that led to the adoption of some of the laws and policies, which helps to make the process more accessible to the reader. - Jeremy Sugarman, M.D., M.P.H., Johns Hopkins University for THE NEW ENGLAND JOURNAL OF MEDICINE(2006) ...a measured walk through most of the beter-known public policy issues revolving around drug research, marketing and use. - PharmaceuticalCommerce.com (2006) Author InformationTab Content 6Author Website:Countries AvailableAll regions |